Aminothiazolones as potent, selective and cell active inhibitors of the PIM kinase family-Reference-Cited by-同舟云学术

Aminothiazolones as potent, selective and cell active inhibitors of the PIM kinase family

Published:2020-11 Issue:22 Volume:28 Page:115724
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Quevedo Camilo E.,Bataille Carole J.R.,Byrne Simon,Durbin Matthew,Elkins Jon,Guillermo Abigail,Jones Alan M.,Knapp Stefan,Nadali Anna,Walker Roderick G.,Wilkinson Isabel V.L.,Wynne Graham M.,Davies Stephen G.,Russell Angela J.

Funder

Cancer Research UK

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference38 articles.

1. Murine leukemia virus-induced T-cell lymphomagenesis: Integration of proviruses in a distinct chromosomal region;Theo Cuypers;Cell,1984

2. PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers;Brault;Haematologica-the Hematology Journal,2010

3. The human protooncogene product P33PIM is expressed during fetal hematopoiesis and in diverse leukemias;Amson;PNAS,1989

4. Fighting Tumor Cell Survival: Advances in the Design and Evaluation of Pim Inhibitors;Anizon;Curr Med Chem,2010

5. Pim kinase inhibitors: a survey of the patent literature;Morwick;Expert Opin Ther Pat,2010

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer;Molecular Diversity;2024-04-20

2. Recent Research Advances in Small-Molecule Pan-PIM Inhibitors;Pharmaceutical Fronts;2022-12